Document ID: chunk:federal_register_of_legislation:F2024C01228:front:0:p3
Version: federal_register_of_legislation:F2024C01228
Segment Type: other
Provision Reference: 
Character Range: 5333–7907

a designated vaccine mentioned in that item may be provided to a person who has congenital or acquired asplenia (e.g. splenectomy) or hyposplenia; a person who has complement deficiency or a person undergoing eculizumab treatment:
 (a) Primary doses according to the following number of doses:
 (i) if aged 6 weeks to 5 months at the start of their vaccine course – 4 doses;
 (ii) if aged 6 to 11 months at the start of their vaccine course – 3 doses; or
 (iii) if aged 12 months or older at the start of their vaccine course – 2 doses;
 (b) plus booster doses according to the following number and timing of doses:
 (iv) if they completed their primary schedule at less than or equal to 6 years of age ‑ 1 booster dose 3 years after completing the primary schedule, and then 1 booster dose every 5 years after that; or
 (v) if they completed their primary schedule at 7 years of age or older ‑ 1 booster dose every 5 years after completing the primary schedule.
 (1B) For item 108C of Schedule 1, the following number of doses and booster doses of a designated vaccine mentioned in that item may be provided to a person who has congenital or acquired asplenia (e.g. splenectomy) or hyposplenia; a person who has complement deficiency or a person undergoing eculizumab treatment:
 (a) primary doses according to the following number of doses:
 (i) if aged 12 months old or older at the start of their vaccine course – 2 doses;
 (b) plus booster doses according to the following number and timing of doses:
 (i) if they completed their primary doses at less than or equal to 6 years of age ‑ 1 booster dose 3 years after completing the primary doses, and then 1 booster dose every 5 years after that; or
 (ii) if they completed their primary doses at 7 years of age or older ‑ 1 booster dose every 5 years after completing the primary doses.
 (1) For item 110 of Schedule 1, a designated vaccine in that item may be provided in the following circumstances:
       (a) a dose of the vaccine may be provided to a child:
 (i) who is an Aboriginal and/or Torres Strait Islander; and
 (ii) who is about 6 months; and
 (iii) who lives in Queensland, Western Australia, South Australia or the Northern Territory;
       (b) a dose of the vaccine may be provided to a person:
 (i) who is about 6 months of age and has one or more of the following medical risk conditions:
 (A) functional or anatomical asplenia including sickle cell disease, other haemoglobinopathies, congenital or acquired asplenia (e.g. splenectomy) or hyposplenia; or
 (B) immunocompromising conditions including